NERV: Minerva Neurosciences, Inc. Stock

by  •  • Comments Off on NERV: Minerva Neurosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15.77
Enterprise Value ($M) 49.24
Book Value ($M) -21.67
Book Value / Share -3.10
Price / Book -0.73
NCAV ($M) -36.55
NCAV / Share -5.23
Price / NCAV -0.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.09
Return on Assets (ROA) -0.06
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 6.23
Current Ratio 6.23

Balance Sheet (mrq) ($M)
Current Assets 27.94
Assets 42.81
Liabilities 64.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Fmr Llc 0.00 -100.00
2024-01-18 13G/A Federated Hermes, Inc. 19.32 12.49

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-22 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ T
2024-02-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TR
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 2,722 8,085 33.67
2025-02-03 1,156 12,152 9.51
2025-01-31 3,677 29,493 12.47
2025-01-30 4,907 43,739 11.22

(click for more detail)

Similar Companies
MTVA – MetaVia Inc. MYNZ – Mainz Biomed N.V.
NATR – Nature's Sunshine Products, Inc. NKTR – Nektar Therapeutics
NLSP – NLS Pharmaceutics AG


Financial data and stock pages provided by
Fintel.io